Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lipoic Acid in Chronic Ischemic Heart Failure: Assessment of Reduction in Major Adverse Cardiovascular Events

NCT07725484 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT07725484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07725484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lipoic Acid in Chronic Ischemic Heart Failure: Assessment of Reduction in Major Adverse Cardiovascular Events
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
December 1, 2030
Enrollment
1,526 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure due to coronary artery disease